FiscalNote to Present at the 26th Annual Needham Growth Conference
Get Alerts NOTE Hot Sheet
Join SI Premium – FREE
WASHINGTON--(BUSINESS WIRE)-- FiscalNote Holdings, Inc. (NYSE: NOTE) ("FiscalNote"), a leading AI-driven enterprise SaaS technology provider of policy and global intelligence, today announced that CEO, Co-Founder, and Chairman Tim Hwang and other senior executives will present at the 26th Annual Needham Growth Conference at 11:45am ET (US) on Friday, January 19, 2024. In addition, the Company plans to hold one-on-one virtual meetings with investors.
A webcast replay and related presentation will be available on the Events & Presentations page of the FiscalNote investor relations website at https://investors.fiscalnote.com/.
For more information about the conference, please contact representatives at Needham & Company.
About FiscalNote
FiscalNote (NYSE: NOTE) is a leader in policy and global intelligence. By uniquely combining data, technology, and insights, FiscalNote empowers customers to manage political and business risk. Since 2013, FiscalNote has pioneered technology that delivers critical insights and the tools to turn them into action. Home to CQ, FrontierView, Oxford Analytica, VoterVoice, and many other industry-leading brands, FiscalNote serves approximately 5,000 customers worldwide with global offices in North America, Europe, Asia, and Australia. To learn more about FiscalNote and its family of brands, visit FiscalNote.com and follow @FiscalNote.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240117405633/en/
Media
Nicholas Graham
FiscalNote
[email protected]
Investor Relations
Sara Buda
FiscalNote
[email protected]
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Honeywell Technologies Launches Forge Plant Cognition with Dangote, Built with NVIDIA AI and Dell Technologies Capabilities
- NTG Nordic Transport Group A/S - Upgrade of guidance for the full year 2026
- CStone Announces Major Clinical Validation Milestone for CS2009 at ESMO 2026: Data from More Than 300 Patients Support Mechanism, Safety and Broad Antitumor Activity
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
Needham & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share